These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 26338007

  • 1. NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair.
    Kucharova K, Stallcup WB.
    J Neuroinflammation; 2015 Sep 04; 12():161. PubMed ID: 26338007
    [Abstract] [Full Text] [Related]

  • 2. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
    Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB.
    J Neuroinflammation; 2011 Nov 13; 8():158. PubMed ID: 22078261
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
    Church JS, Milich LM, Lerch JK, Popovich PG, McTigue DM.
    Glia; 2017 Jun 13; 65(6):883-899. PubMed ID: 28251686
    [Abstract] [Full Text] [Related]

  • 5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

  • 6. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
    Santiago González DA, Cheli VT, Zamora NN, Lama TN, Spreuer V, Murphy GG, Paez PM.
    J Neurosci; 2017 Oct 18; 37(42):10038-10051. PubMed ID: 28899915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
    Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Nait Oumesmar B.
    Glia; 2013 Oct 18; 61(10):1659-72. PubMed ID: 23918253
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
    Lau LW, Keough MB, Haylock-Jacobs S, Cua R, Döring A, Sloka S, Stirling DP, Rivest S, Yong VW.
    Ann Neurol; 2012 Sep 18; 72(3):419-32. PubMed ID: 23034914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
    Talbott JF, Loy DN, Liu Y, Qiu MS, Bunge MB, Rao MS, Whittemore SR.
    Exp Neurol; 2005 Mar 18; 192(1):11-24. PubMed ID: 15698615
    [Abstract] [Full Text] [Related]

  • 15. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells.
    Ulrich R, Seeliger F, Kreutzer M, Germann PG, Baumgärtner W.
    Neuropathol Appl Neurobiol; 2008 Dec 18; 34(6):603-20. PubMed ID: 18466224
    [Abstract] [Full Text] [Related]

  • 16. The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
    Stoffels JM, Hoekstra D, Franklin RJ, Baron W, Zhao C.
    Glia; 2015 Feb 18; 63(2):242-56. PubMed ID: 25156142
    [Abstract] [Full Text] [Related]

  • 17. NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
    Ferrara G, Errede M, Girolamo F, Morando S, Ivaldi F, Panini N, Bendotti C, Perris R, Furlan R, Virgintino D, Kerlero de Rosbo N, Uccelli A.
    Acta Neuropathol; 2016 Jul 18; 132(1):23-42. PubMed ID: 27026411
    [Abstract] [Full Text] [Related]

  • 18. Dissecting the multifactorial nature of demyelinating disease.
    Kucharova K, Stallcup WB.
    Neural Regen Res; 2018 Apr 18; 13(4):628-632. PubMed ID: 29722306
    [Abstract] [Full Text] [Related]

  • 19. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B.
    Ann Neurol; 2009 Mar 18; 65(3):304-15. PubMed ID: 19334062
    [Abstract] [Full Text] [Related]

  • 20. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A, Deboux C, Bachelin C, Frah M, Kerninon C, Seilhean D, Weider M, Wegner M, Nait-Oumesmar B.
    Brain; 2015 Jan 18; 138(Pt 1):120-35. PubMed ID: 25564492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.